Clinical Trials Browser

Phase 2 × Vomiting × Thoracic × Clear all

NCT02445872 2015-12-09

Safety and Efficacy of Aprepitant for CINV in Patients With Lung Cancer Receiving Multiple-day Cisplatin Chemotherapy

Phase 2 Unknown

Lung Neoplasms, Nausea, Vomiting

NCT02407600 2015-04-03

Study Assessing Fosaprepitant in Advanced NSCLC Patients Treated With Carboplatin Based Chemotherapy

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Nausea, Vomiting